根据 3 位华尔街分析师的预测,Avanos Medical Inc 的收入预期范围从 $178.5M 到 $166.6M
Avanos Medical Inc 的盈利质量评分是多少?
Avanos Medical Inc 的盈利质量评分为 B+/53.02908。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Avanos Medical Inc 何时发布财报?
Avanos Medical Inc 的下一份财报预计在 2026-05-25 发布
Avanos Medical Inc 的预期收益是多少?
根据华尔街分析师的预测,Avanos Medical Inc 的预期收益为 $178.19M
Avanos Medical Inc 是否超出收益预期?
Avanos Medical Inc 最近的收益为 $180.9M,超出预期 预期。
关键数据
前收盘价
$13.65
开盘价
$13.81
当日区间
$13.6 - $14.7
52周范围
$9.3 - $15.68
交易量
415.1K
平均成交量
580.7K
股息收益率
--
每股收益(TTM)
-1.58
市值
$683.6M
什么是 AVNS?
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.